Search hospitals > California > Orange
Saint Joseph Hospital - Orange
Claim this profileOrange, California 92868
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
160 reported clinical trials
15 medical researchers
Summary
Saint Joseph Hospital - Orange is a medical facility located in Orange, California. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Saint Joseph Hospital - Orange is involved with conducting 160 clinical trials across 296 conditions. There are 15 research doctors associated with this hospital, such as Timothy E. Byun, Bhavraj S Khalsa, MD, Robert B. Ash, and Brian Kolski, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Timothy E. ByunSaint Joseph Hospital - Orange8 years of reported clinical research
Studies Lung Cancer
Studies Breast cancer
30 reported clinical trials
84 drugs studied
Bhavraj S Khalsa, MDSt. Joseph Hospital5 years of reported clinical research
Studies Central Venous Access Device Thrombosis
Studies Venous Stasis Syndrome
6 reported clinical trials
7 drugs studied
Robert B. AshSaint Joseph Hospital - Orange9 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
22 drugs studied
Brian Kolski, MDSt. Joseph Hospital7 years of reported clinical research
Studies Von Willebrand Disease
Studies Aortic Valve Stenosis
4 reported clinical trials
5 drugs studied
Clinical Trials running at Saint Joseph Hospital - Orange
Lung Cancer
Breast Cancer
Cancer
Ovarian Cancer
Pancreatic Cancer
Pancreatic Carcinoma
Endometrial Cancer
Uterine Cancer
Non-Small Cell Lung Cancer
Breast cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
INBRX-106 + Pembrolizumab
for Lung Cancer
This is a Phase 1/2, open-label, non-randomized, 4-part trial to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX 106 administered as a single agent or in combination with the anti-PD-1 checkpoint inhibitor (CPI) pembrolizumab (Keytruda®). KEYTRUDA is a registered trademark of Merck Sharp \& Dohme LLC, a subsidiary of Merck \& Co., Inc., Rahway, NJ, USA.
Recruiting1 award Phase 1 & 25 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Joseph Hospital - Orange?
Saint Joseph Hospital - Orange is a medical facility located in Orange, California. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Saint Joseph Hospital - Orange is involved with conducting 160 clinical trials across 296 conditions. There are 15 research doctors associated with this hospital, such as Timothy E. Byun, Bhavraj S Khalsa, MD, Robert B. Ash, and Brian Kolski, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.